Witnessing the stock’s movement on the chart, on Thursday, RAPT Therapeutics Inc (NASDAQ: RAPT) set off with pace as it heaved 10.98% to $33.26, before settling in for the price of $29.97 at the close. Taking a more long-term approach, RAPT posted a 52-week range of $5.67-$42.39.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -10.10%. Meanwhile, its Annual Earning per share during the time was -10.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 90.64%. This publicly-traded company’s shares outstanding now amounts to $27.71 million, simultaneously with a float of $17.87 million. The organization now has a market capitalization sitting at $921.66 million. At the time of writing, stock’s 50-day Moving Average stood at $28.08, while the 200-day Moving Average is $14.12.
RAPT Therapeutics Inc (RAPT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. RAPT Therapeutics Inc’s current insider ownership accounts for 35.50%, in contrast to 30.07% institutional ownership.
RAPT Therapeutics Inc (RAPT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year. RAPT Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 90.64% and is forecasted to reach -3.36 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 45.47% through the next 5 years, which can be compared against the -10.10% growth it accomplished over the previous five years trading on the market.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
In the same vein, RAPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -11.07, a figure that is expected to reach -0.75 in the next quarter, and analysts are predicting that it will be -3.36 at the market close of one year from today.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Going through the that latest performance of [RAPT Therapeutics Inc, RAPT]. Its last 5-days volume of 0.46 million indicated improvement to the volume of 0.2 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 84.61% While, its Average True Range was 74.57.
Raw Stochastic average of RAPT Therapeutics Inc (RAPT) in the period of the previous 100 days is set at 73.41%, which indicates a major fall in contrast to 84.98% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.77 that was higher than 1.75 volatility it exhibited in the past 100-days period.
